Lysergic acid diethylamine for generalized anxiety disorder

Related articles

1. Trustworthiness issues in Yari-Renani and Zari (2025) “Advancing depression treatment: a multi-center randomized controlled trial of dynamic interpersonal therapy versus CBT and pharmacotherapy on symptoms, sleep, and cognition”

   This article has 3 authors:

   1. Martin Plöderl
   2. Ian Hussey
   3. Michael Ostacher

2. WITHDRAWN: Effects of Vitamin D Supplementation on Gherlin and Leptin Hormones in Patients with Major Depressive Disorder

   This article has 7 authors:

   1. Shareefa AlGhamdi
   2. Nabilah Alsulami
   3. Sawsan Khoja
   4. Hadeil Alsufiani
   5. Haythum O. Tayeb
   6. Huda AlShaibi
   7. Frank I. Tarazi

3. Concerning harm/benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process

   This article has 5 authors:

   1. Martin Plöderl
   2. Mark Horowitz
   3. Florian Naudet
   4. John Warren
   5. Joanna Moncrieff